GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Lukang Pharmaceutical Co Ltd (SHSE:600789) » Definitions » Gross-Profit-to-Asset %

Shandong Lukang Pharmaceutical Co (SHSE:600789) Gross-Profit-to-Asset % : 12.55% (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Shandong Lukang Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Shandong Lukang Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Sep. 2024 was ¥1,129 Mil. Shandong Lukang Pharmaceutical Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥8,997 Mil. Therefore, Shandong Lukang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was 12.55%.


Shandong Lukang Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Lukang Pharmaceutical Co Gross-Profit-to-Asset % Chart

Shandong Lukang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.46 13.65 15.60 15.08 17.29

Shandong Lukang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.17 19.20 19.48 13.73 12.55

Competitive Comparison of Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset % falls into.



Shandong Lukang Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Shandong Lukang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=1515.453/( (8727.665+8802.431)/ 2 )
=1515.453/8765.048
=17.29 %

Shandong Lukang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=1128.952/( (8843.331+9150.039)/ 2 )
=1128.952/8996.685
=12.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Shandong Lukang Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Shandong Lukang Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Lukang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 152 Taibai West Road, Jining, Shandong, CHN, 272021
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.
Executives
Zhao Wei Director
Peng Xin Director
Dong Kun Director
He De Feng senior management
Gao Xiang You Director
Cheng Jun Director

Shandong Lukang Pharmaceutical Co Headlines

No Headlines